European Association for the Study of Diabetes

👏 Heartfelt congratulations to Prof. Chantal Mathieu on her new role as Chair of the @eudiabetesforum.bsky.social, & to Prof. Francesco Giorgino as the new Vice-Chair.

Our deepest thanks to Prof. Stefano Del Prato for his inspiring leadership & lasting impact on #diabetes #research & #care.

Banner for the EASD Robert Turner Clinical Research Training Course, taking place 16–20 March 2026 in Oxford, UK. Includes a red corner label reading ‘Apply Now!’ and images of Oxford landmarks, including the Radcliffe Camera and surrounding university buildings. The logo of the European Association for the Study of Diabetes (EASD) and website easd.org are displayed at the bottom.

🚨 Early career #researchers don’t miss your chance to apply for the EASD Robert Turner Clinical Research Training Course!🌍Enhance your research skills & connect with peers:

📅 16 - 20 March 2026, Oxford, UK
🔗 Application deadline: 5 Jan 2026

Apply now 👉 www.easd.org/education/me...

#Diabetes

A group of four people sit in chairs having a panel discussion, holding blue microphones, in front of a wooden wall. The design overlay includes the EASD logo and a soundwave graphic. Text reads: “Rising Stars: the future of diabetes research.

🎙️ New #podcast episode out now!

Listen to the #easd2025 Rising Stars in #diabetes #research - Four young scientists shaping the future of diabetes share what drives their research & their hopes for the next decade in diabetes science.

🎧👉 Listen now: www.easd.org/mediacentre/...

EndoCompass project: research roadmap for diabetes, obesity, and metabolism AbstractBackground. Endocrine science remains underrepresented in European Union research programmes despite the fundamental role of hormone health in huma

🔬 #EndoCompass Research Roadmap charts the future of endocrine science. #EUresearch must tackle #diabetes, #obesity & #metabolism, focusing on #genetics, brain-periphery crosstalk, #environment & new therapies.

Read more 👉 academic.oup.com/ejendo/artic...

@esendocrinology.bsky.social

📣 This month marks a moment of transition for us, as we extend our deep thanks and warm farewells to Prof. Stefano Del Prato, who concludes his term as Chair. Having first served as Vice-Chair for two years, followed by two years as Chair, Prof. Del Prato has been an impactful force in EUDF.

🎉 Exciting news: @metabologiajnl.bsky.social, the new sister journal to @diabetologiajnl.bsky.social, is now open for submissions!

Welcoming high-quality research in #metabolism & #diabetes. 📢 Submit your papers now & help shape the journal’s first volume.

Still wondering how to pronounce it? 🗣️👇

Graphic announcing the EFSD/Novo Nordisk Foundation Future Leaders Award 2025 recipients. The banner features blue, green, and turquoise colours with circular design elements. The text reads: ‘EFSD/Novo Nordisk Foundation Future Leaders Award - 2025 Award Recipients.’ Listed recipients: Joan Camunas-Soler, University of Gothenburg, Sweden; Martin Schön, German Diabetes Center, Germany; Rasmus Kjøbsted, University of Copenhagen, Denmark; and Amna Khamis, University of Lille, France. At the bottom are the EFSD logo and website: europeandiabetesfoundation.org.

🎉👏Congrats to the 2025 #EFSD/ Novo Nordisk Foundation #FutureLeaders Award #recipients! Supporting scientists & clinicians in EU #diabetes #research as they transition into independent faculty roles.

Stay tuned for updates on their projects!

🔗👉 www.europeandiabetesfoundation.org/recipients/e...

Two scientific charts showing long-term diabetes outcomes. Left chart titled ‘Proportion of individuals without type 2 diabetes over time’ displays a survival curve comparing responders (in blue) and nonresponders (in red) over 10 years. The y-axis shows the percentage of individuals with no progression to type 2 diabetes, and the x-axis shows time in years. Responders maintain a higher proportion without diabetes compared to nonresponders. Statistical note: p = 0.004. Right chart titled ‘Glycaemic categories over time’ presents stacked bar graphs showing the number of participants with type 2 diabetes (green), prediabetes (yellow), and normal glucose regulation (light green) at different follow-up points (intervention outcome, 1, 2, 5, and 8 years). It includes a label indicating ‘Relative risk of type 2 diabetes: 0.29 (95% CI: 0.09–0.91, p = 0.02).

👉 1 in 5 with #prediabetes achieved normal glucose regulation w/out weight loss – reducing their relative risk of #T2D by 71%.
Prevention guidelines centred on weight-loss targets risk overlooking an effective, patient-relevant goal, warns co-PI Andreas Birkenfeld: easd-elearning.eu/news/458/Rev...

⏰Last call! Don’t miss the opportunity to join the EASD Early Career Academy #Mentorship programme. A 1-year long programme aimed at connecting #earlycareer #researchers to leading experts in the field!

🗓️ Deadline: 3 Nov 2025, 12:00 CET

👉 Apply now: www.easd.org/academy/acad...

#diabetes

Graphic titled ‘Recipient Research Portrait’ featuring Doctor Liva Sophie Lavlund Krogh from the Center for Clinical Metabolic Research, Gentofte Hospital. The design includes a portrait photo of her smiling, along with EFSD, European Foundation for the Study of Diabetes, branding.

Graphic titled ‘Separate and combined extrapancreatic effects of the incretin hormones.’ Text explains that Liva Sophie Lavlund Krogh investigates the extrapancreatic effects of the incretin hormones GIP and GLP-1 in totally pancreatectomized patients, showing their impact on various tissues independent of pancreatic insulin and glucagon. EFSD logo included.

Graphic with EFSD branding stating that the research is supported by the EFSD/Novo Nordisk A/S Programme for Diabetes Research in Europe. The lower section invites viewers to apply for research grants and fellowships at europeandiabetesfoundation.org

🧠 Meet Dr. Liva Krogh (Center for Clinical Metabolic Research), co-Investigator & #grant recipient of the #EFSD/ @novonordisk.bsky.social A/S Programme for Diabetes Research in 🇪🇺 for how GIP & GLP-1 affect tissues beyond the pancreas.

Learn more 👉 www.europeandiabetesfoundation.org/programmes.h...

⏰📢 Last call! Have your say on the @easdnews.bsky.social diabetes distress guideline!

Open consultation closes 31 October 2025.

Scan the QR code to share your feedback or go to 👉 www.easd.org/guidelines/s...

#Diabetes #ClinicalGuideline #T1D #T2D

🔁The EASD Early Career Academy continues its #Webinar series! Next on #WorldDiabetesDay: Prof. Gernot Desoye ( @medunigraz.at ) explores how the #placenta influences #pregnancy outcomes and fetal development.

📅 14 November 2025 |🕛 16:00 pm CET

Register now 👉 us06web.zoom.us/webinar/regi...

Announcement from the European Association for the Study of Diabetes (EASD) advertising the position of Editor-in-Chief, Diabetologia. The text invites accomplished physicians and scientists to apply to lead the journal, which publishes clinical, translational, and experimental research on diabetes. Includes application details via https://tinyurl.com/diab-eic-job-ad, contact email diabetologia-j@bristol.ac.uk, and notes the closing date for applications as 17 November 2025.

📢 Job Opportunity: @easdnews.bsky.social is seeking an Editor-in-Chief for its flagship journal, @diabetologiajnl.bsky.social .

Lead one of the world’s top #diabetes #research journals.

🔗 Apply now: tinyurl.com/diab-eic-job...

🗓️ Closing date: 17 Nov 2025

#Diabetologia #Vacancy #EditorInChief

A smiling Dr. Viswanathan Mohan in a suit and patterned tie speaks into a blue microphone labeled “EASD Live.” The background has blue circular design elements and the EASD logo. Text on the image reads, “Impacting lives with diabetes in resource constrained settings.

🌏 With >100 million people living with diabetes, how can we create lasting impact?

Dr. V. Mohan, recipient of the inaugural EASD #GlobalImpactPrize, shares 50 years of work shaping diabetes prevention, #education & #care in India.

🎧👉 Listen now: easd.org/media-centre/podcasts.html

#podcast

⏰ Reminder! You can still share your thoughts on the @easdnews.bsky.social guideline for assessing & managing diabetes distress among adults with #t1d & #t2d.

Consultation is open until 31 Oct 2025.

Give your input here 👉 www.easd.org/guidelines/s...

#Diabetes #DiabetesCare #ClinicalGuidelines

Banner for the 1st Immunology School for Endocrinology, taking place 26–27 March 2026 in Vienna, Austria. Organized by the European Association for the Study of Diabetes (EASD). The right side of the banner shows images of virus-like structures and a healthcare professional performing a finger-prick blood test.

Don't miss our first Immunology School for Endocrinology! Led by Prof. Chantal Mathieu & Prof. Julia Mader, this 2-day course covers immunology in #T1D, from new concepts to beta-cell replacement.

📅 26 - 27 March 2026 |📍 Vienna

🕛 Application Deadline: 30 Nov 2025

🔗👉 www.easd.org/education/me...

Graphic announcing CME certificates for the 61st EASD Annual Meeting. The banner features a red background with blue and white text reading: ‘61st EASD Annual Meeting, 15 - 19 September 2025, Vienna, Austria.’ Below, a white and blue section says: ‘Now available - CME Certificates. EASD 2025 participants can now download their EACCME Certificate.’ The EASD 2025 Vienna logo appears in the top left corner, and the EASD logo with website easd.org is at the bottom.

📜 Certificates Now Available!

#easd2025 registered participants can now download their EACCME certificates as well as their Certificates of Attendance for the Annual Meeting directly from their #MyEASD account.

🔗👉 For more, visit: www.easd.org/annual-meeti...

#Diabetes #Certification #CME

Can #CGM use of just 10 to 15 days at a time make a difference in #T2D?

Dr. @dramitaol.bsky.social explains how intermittent CGM helps personalise care, optimise treatment & support #lifestyle modifications.

🎥👉 Watch now: easd-elearning.eu/episode/345/...

#Diabetes #technology #GlycaemicControl

Call to action encouraging applications for research grants and fellowships at europeandiabetesfoundation.org. The image notes support from the EFSD/Boehringer Ingelheim European Research Programme on 'Multi-System Challenges in Diabetes.'

Research summary titled 'Targeting obesity and diabetes through microbiome-tailored bile acid signalling.' It explains Professor Kristina Schoonjans' investigation into using the gut bacterium Clostridium scindens to restore metabolic balance in obese mice and potentially develop a probiotic strategy against metabolic diseases like obesity and type 2 diabetes.

Call to action encouraging applications for research grants and fellowships at europeandiabetesfoundation.org. The image notes support from the EFSD/Boehringer Ingelheim European Research Programme on 'Multi-System Challenges in Diabetes.'

Meet Prof. Kristina Schoonjans ( #EPFL), recipient of the #EFSD/#Boehringer Ingelheim European Research Programme grant. Her team explores how Clostridium scindens may prevent obesity & #t2d by restoring metabolic balance through bile acid signalling.

📖 Learn more👉 www.embopress.org/doi/epdf/10....

👏 Take advantage of the EASD #EarlyCareer Academy Mentorship Programme, still open for applications!

An Excellent opportunity for early-career diabetes researchers & clinicians to gain mentorship, insights & EU networking support.

🗓️ Deadline: 3 Nov 2025, 12:00 CET

🔗👉 www.easd.org/academy/acad...

Stylized graphic featuring overlapping circular shapes in light blue and white, framing screenshots of the EASD (European Association for the Study of Diabetes) Media Centre website. The website interface displays various publication covers from past years, a world map of viewer locations, and media content. The background is a gradient of blue tones.

🎥 Missed the #EASD2025 Annual Meeting in Vienna?

All presentations & webcasts are now available for free in our EASD Media Centre.

Explore the latest insights in #diabetes #research & catch up on the latest breakthroughs shaping the future of Diabetes #care 🔬

👉 www.easd.org/media-centre...

✨📢 Share your thoughts!

@easdnews.bsky.social has released its 1st evidence-based #clinical practice #guideline on the assessment & management of #diabetes #distress in adults with #t1d & #t2d.

The consultation period is open until 31 October 2025!

Scan QR or click👉 www.easd.org/guidelines/s...

The image announces the 2025 EFSD/Lilly Young Investigator Research Award Programme recipients. The awardees and their affiliations are: Ben Stocks – University of Copenhagen, Denmark Mikkel Thor Olsen – Steno Diabetes Center Copenhagen, Denmark Lucas Massier – Helmholtz Munich, Germany Carla Horváth – ETH Zurich, Switzerland Ever Espino Gonzalez – University of Copenhagen, Denmark Dipsikha Biswas – University of Copenhagen, Denmark The announcement is presented by EFSD (European Foundation for the Study of Diabetes), and more information can be found at europeandiabetesfoundation.org.

🎉👏 We’re thrilled to congratulate the 2025 #EFSD / Lilly Diabetes International Young Investigators Award recipients.

Award recognises early career scientists/clinicians driving innovation in diabetes research.

Learn more about their projects 👉 www.europeandiabetesfoundation.org/recipients/e...

💬“Guidelines only matter if they change lives.” Hear from Michelle Law about her experience on the #DiabetesDistress Guideline Development Panel of our 1st-ever evidence-based clinical #guideline!

🎥Watch now: easd-elearning.eu/episode/349/...

🗳️Have your say: www.easd.org/guidelines/s...

#Diabetes

Graphic introducing Jacinto López Sagaseta, Principal Investigator at Navarrabiomed Pamplona, as a recipient featured in the EFSD Research Portrait series. The European Foundation for the Study of Diabetes (EFSD) logo appears at the bottom.

Graphic describing Jacinto López Sagaseta’s research on the structural basis for the fate and pathogenicity of autoreactive T cells in type 1 diabetes. It explains how his work investigates MHC-II variants and T cell recognition of insulin peptides to understand why some people develop type 1 diabetes while others do not. EFSD logo shown at the bottom

Graphic stating the research is supported by the EFSD/Lilly European Diabetes Research Programme. It encourages applications for research grants and fellowships, with the website europeandiabetesfoundation.org displayed at the bottom

🔬Meet Dr. Jacinto López Sagaseta (@navarrabiomed.bsky.social ), 2022 #EFSD/ Lilly Awardee. His work uncovers the structural basis of autoreactive T cell recognition, to explain why factors like MHC-II variants like I-Ab may afford protection.

📖 www.frontiersin.org/articles/10....

#diabetesgrant

📢 Applications are still open for the EASD Albert Renold Travel #Fellowship programme. Take this chance to gain new skills, expand your network, & elevate your diabetes research abroad.

📅 Deadline: 3 Nov 2025

📌Apply via the #EFSD Programme Portal: www.europeandiabetesfoundation.org/programmes/p...

⏳ Last chance to register! Join Profs Niklas Mejhert & Mikael Rydén (@ki.se ) tomorrow for the Early Career Academy #webinar on using high-resolution spatial approaches to study human #whiteadiposetissue.

🗓️ 14 Oct 2025 |🕓17:00 CEST

👉 Register here: us06web.zoom.us/webinar/regi...

#diabetes #ECA

Promotional graphic for a “Diabetes Insights: Breakthroughs and Innovators” podcast episode by EASD (European Association for the Study of Diabetes). It features a woman speaking into a microphone labeled “EASD LIVE,” and the title of the podcast is “The role of the pancreas in type 2 diabetes.” The design includes blue tones with a stylized waveform, suggesting it’s an audio-focused presentation or recording

💡 Can we predict type 2 diabetes before it begins? Dr Teresa Mezza, recipient of the 60th EASD Minkowski Prize, shares how studying patients after partial pancreatectomy reveals early biomarkers that could transform prevention.
🎧👉 www.easd.org/media-centre...
#Diabetes #Minkowski #Pancreas #Podcast

⏰ The #EASD2025 Virtual Meeting Platform (VMX) closes on 17 October 2025! Last chance to catch up on the groundbreaking science & earn #CME credits.

Enjoy a look at #easd2025 by the numbers👇

Log in with your MyEASD credentials before it closes - virtualcongress.easd.org

#medicaleducation

Promotional graphic for the “1st Immunology School for Endocrinology,” taking place on 26-27 March 2026 in Vienna, Austria. The design features a blue gradient background with white and turquoise text. On the right side, there are images of a gloved hand performing a finger-prick blood test and stylized blue virus-like illustrations. At the bottom, the EASD (European Association for the Study of Diabetes) logo and the website “easd.org” are displayed.

📢 EASD will host its 1st Immunology School for Endocrinology: #Immunology in #Type1Diabetes - bridging the science and clinical impact.

📅 26 - 27 March 2026 |📍Vienna, Austria

Open to EASD Members; doctors, researchers/pharmacists in endocrinology/diabetology.

Apply 👉 www.easd.org/education/me...